Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate ...

This Monday, February 10, ahead of International Childhood Cancer Day, Hyundai Canada and its 226 dealers nationwide will launch Hyundai Hope On Wheels in Canada, a registered non-profit dedicated to ...

February is Heart Month, a time to focus on the health and well-being of Ontarians. In recognition of this, and in advance of the upcoming provincial election, we are calling on all political parties ...

This Research Topic seeks original research, reviews, and meta-analyses on topics such as strategic nanocomplex-mediated modulation of the tumor microenvironment, novel smart nanocomplexes with ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

创伤、手术和全身性疾病经常导致不可逆的骨质流失，带来严重的痛苦和相当大的经济压力。钛基金属等传统成骨生物材料缺乏有效的成骨能力，需二次手术去除。基于聚合物的植入物和有机/无机杂化材料具备良好的生物相容性，被广泛用于骨软骨修复。然而，这些材料通常机械强 ...

Sustained Immunomodulation: SAB-142 demonstrated a clinically validated multi-target MOA with sustained immunomodulation. MoA ...

SAB BIO (NASDAQ:SABS) released topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy ...

Edmund Lui made ginseng the focus of his academic research and now he's sharing his passion for the herb at his London market ...

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market capitalization of $87 million, has announced promising preclinical results for ...

Sustained Immunomodulation: SAB-142 demonstrated a clinically validated multi-target MOA with sustained immunomodulation. MoA Analogous to Rabbit ATG: The mechanism of action (MoA) of SAB-142 ...

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...